United States· US:55289-090_41999499-b90e-0afa-e063-6294a90aea28
Triamterene and Hydrochlorothiazide
A medicinal product containing triamterene; hydrochlorothiazide, registered in United States by PD-Rx Pharmaceuticals, Inc..
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- TRIAMTERENE; HYDROCHLOROTHIAZIDE
- Manufacturer
- PD-Rx Pharmaceuticals, Inc.
- Country
- United States (US)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 6
- ndc11552890901515 TABLET in 1 BOTTLE, PLASTIC (55289-090-15)
- ndc11552890903030 TABLET in 1 BOTTLE, PLASTIC (55289-090-30)
- ndc11552890909090 TABLET in 1 BOTTLE, PLASTIC (55289-090-90)
- ndc1155289-090-15
- ndc1155289-090-30
- ndc1155289-090-90
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Triamterene; hydrochlorothiazide in 4 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- GermanyDytide HMibe Gmbh Arzneimittel
- CanadaAPO TRIAZIDEAPOTEX INC
- FinlandTriamtexOrion Corporation Orion Pharma
- FrancePRESTOLE, géluleALMIRALL
Authorised across Europe · EMA
The same active substance is authorised in 6 EEA countries. Names it is sold under:
- Austria · Dytide H
- Bulgaria · Диуретидин, Триампур Композитум
- Germany · Dytide H, Triampur Compositum
- France · Prestole
- Netherlands · Triamtereen/Hydrochloorthiazide Accord
- Portugal · Dyazide
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/b766086b-cbd6-47e4-b2a9-a53cf29b53cb GET /v1/drugs/b766086b-cbd6-47e4-b2a9-a53cf29b53cb?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "ORAL",
"source": "ndc",
"strength": "37.5; 25",
"substance": "TRIAMTERENE; HYDROCHLOROTHIAZIDE",
"productndc": "55289-090",
"dosage_form": "TABLET",
"dea_schedule": null,
"strength_unit": "mg/1; mg/1",
"application_number": "ANDA073449",
"marketing_category": "ANDA"
}See everything about triamterene; hydrochlorothiazide.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.